載入...
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
The transcription factor FOXM1 is upregulated and overexpressed in aggressive, therapy-resistant forms of hormone receptor-positive and triple negative breast cancers, and is associated with less good patient survival. FOXM1 signaling is also a key driver in many other cancers. Here, we identify a n...
Na minha lista:
| 發表在: | NPJ Breast Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6884575/ https://ncbi.nlm.nih.gov/pubmed/31815181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0141-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|